AdvisorShares Investments LLC lowered its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 28.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,151 shares of the biopharmaceutical company’s stock after selling 1,621 shares during the period. AdvisorShares Investments LLC’s holdings in Intra-Cellular Therapies were worth $297,000 at the end of the […]
Sectoral Asset Management Inc. cut its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 94.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,420 shares of the biopharmaceutical company’s stock after selling 116,260 shares during the period. Sectoral Asset Management Inc.’s holdings […]
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) has received an average rating of “Moderate Buy” from the ten ratings firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year target price among […]
Intra-Cellular Therapies (NASDAQ:ITCI) Announces Earnings Results, Beats Estimates By $0.15 EPS dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Analysts Issue Forecasts for Intra-Cellular Therapies, Inc.'s FY2025 Earnings (NASDAQ:ITCI) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.